![Stuart McLachlan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stuart McLachlan
Corporate Officer/Principal bei Lypanosys Pte Ltd.
Profil
Stuart McLachlan is currently working as the Executive Vice President-Clinical Trials at Lypanosys Pte Ltd.
He holds a doctorate degree from the University of California, Davis.
Aktive Positionen von Stuart McLachlan
Unternehmen | Position | Beginn |
---|---|---|
Lypanosys Pte Ltd.
![]() Lypanosys Pte Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys Pte Ltd. engages in the development of clinically differentiated drug for dermatology. Its initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis. The company was founded in 1997 and is headquartered in Singapore. | Corporate Officer/Principal | 06.06.2011 |
Ausbildung von Stuart McLachlan
University of California, Davis | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Lypanosys Pte Ltd.
![]() Lypanosys Pte Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys Pte Ltd. engages in the development of clinically differentiated drug for dermatology. Its initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis. The company was founded in 1997 and is headquartered in Singapore. | Health Technology |